(b).
Relapse-free survival | ||||
---|---|---|---|---|
rs12459419 genotypes | Genetic risk (ELN 2010) | N | Median (95% CI) | P |
CC | Global | 32 | 1.5 y (1.1-1.9) | 0.5 |
Favorable risk | 15 | 1.7 y (1.3-2.7) | 0.6 | |
Intermediate risk | 11 | 1.4 y (1.3-1.6) | 0.6 | |
Adverse risk | 4 | 0.2 y (NC-1.2) | 0.4 | |
CT/TT | Global | 38 | 1.7 y (0.7-2.6) | 0.5 |
Favorable risk | 13 | 2.7 y (NC-7.5) | 0.6 | |
Intermediate risk | 16 | 1.6 y (NC-9.4) | 0.6 | |
Adverse risk | 5 | 0.6 y (0.3-0.8) | 0.4 |
Abbreviations: ELN: European Leukemia Net; CI: confidence interval; NC: not calculable.